Developments in artificial intelligence (AI) and machine learning (ML) are playing an increasingly influential role in the pharma sector. Our client provides an overview of developments in the AI healthcare sector which include overcoming the legal, regulatory and commercial hurdles in this high growth area.

Our client, leading Intellectual Property firm Mathys & Squire, has now launched an initiative called Scaleup Quarter, specifically aimed at growing businesses and entrepreneurs to build a community where businesses, individuals, investors, supporters and advisers can come together to connect around all IP matters. As IP only makes up one part of a scaleup’s journey, […]